Kids under 16 will no longer be allowed to livestream on Instagram without parental consent [deltaMinutes] mins ago Now
Day: April 8, 2025
Vertex Pharmaceuticals VRTX announced that the European Commission (EC) has expanded the label of its blockbuster cystic fibrosis (CF) drug, Kaftrio, to treat all patients aged two years and older who have at least one non-class I mutation in the CFTR gene. This approval was expected as the EMA’s Committee for Medicinal Products for Human Use (“CHMP”) issued a positive opinion recommending Kaftrio’s approval in February for the above indication….